Margaret Dalesandro Seelos Therapeutics, Inc. (SEEL) insider trading activity

Margaret Dalesandro is Director of SEELOS THERAPEUTICS, INC.. Currently has a direct ownership of 35,000 shares of SEEL, which is worth approximately $13,300. The most recent transaction as insider was on May 26, 2022, when has been sold 35,000 shares (Common Stock) at a price of $0.6 per share, resulting in proceeds of $21,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35K

0% 3M change

0% 12M change

Total Value Held $13,300

MARGARET DALESANDRO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 26 2022	BUY Open market or private purchase	$21,000 $0.6 p/Share	35,000 Added 50.0%	35,000 Common Stock

Also insider at

ONCS

ONCOSEC MEDICAL Inc Healthcare

Director

SKYE

Skye Bioscience, Inc. Healthcare

Director

AMAM

Ambrx Biopharma Inc. Healthcare

AMAM

Ambrx Biopharma, Inc.